Drugs / HLIM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03827590 | Nov 2018 → May 2019 | bronchitis, respiratory tract infectious disorder | SamA Pharmaceutical Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HLIM | “HLIM+SA160021 Placebo+SA160022 Placebo” NCT03827590 ↗ |